🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
1.740
-0.020 (-1.14%)
At close: Nov 20, 2026, 4:00 PM EST
1.700
-0.040 (-2.30%)
After-hours: Nov 20, 2026, 6:52 PM EST

enGene Therapeutics Market Cap

enGene Therapeutics has a market cap or net worth of $116.61 million as of November 20, 2026. It is the 23,522nd most valuable company in the world and the 3,873rd biggest in the United States. Its market cap has decreased by 74.20% in one year.

Market Cap
116.61M
Enterprise Value
-116.44M
1-Year Change
-74.20%
Global Rank
Country Rank
#3,873 United States
Category

Chart

Chart

Since February 1, 2022, enGene Therapeutics's market cap has decreased from $155.91M to $116.61M, a decrease of -25.21%. That is a compound annual growth rate of -5.87%.

History

DateMarket Cap% Change
Nov 20, 2026116.61M-80.72%
Dec 31, 2025604.87M78.43%
Dec 31, 2024338.99M58.32%
Dec 29, 2023214.12M31.08%
Dec 30, 2022163.34M4.77%
Feb 1, 2022155.91M-

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

CompanyMarket Cap
MacroGenics125.26M
Compass Therapeutics123.94M
Humacyte123.73M
Satellos Bioscience122.07M
Invivyd122.01M
Adagene118.17M
Armata Pharmaceuticals112.69M
Fate Therapeutics111.72M
Market Cap Rankings